STAT6 and carcinoma: IL-4 was able to stimulate phosphorylation of STAT6 at significantly lower doses than IL-13 in the human epithelial carcinoma cell line A549 [73], suggesting that STAT6 may not be the main downstream molecular target of IL-13.